galectin-3 inhibitors (Idorsia Pharmaceuticals/leadXpro)

N/A

Report date: 2025/06/11 10:38:42
NME

Base Information

Drug Namegalectin-3 inhibitors (Idorsia Pharmaceuticals/leadXpro)
Drug Alias NameN/A
ClassificationSmall molecules
Mechanisms of ActionGalectin-3 inhibitors
TargetsGalectin-3
Therapy Area/IndicationsInflammationFibrosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySwitzerland
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesIdorsia Pharmaceuticals Ltd
China Registration ClassN/A

Develop Information

Active CompaniesleadXpro AGIdorsia Pharmaceuticals Ltd
Inactive CompaniesN/A
Active IndicationsInflammationFibrosis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A